Researchers are excited about the medication , a groundbreaking dual treatment showing remarkable data in clinical trials for weight reduction . It acts by targeting both pathways : GLP-1 and GIP, which https://haimarosr167112.bloggactif.com/42218375/the-new-possibility-for-body-reduction